Resurge Therapeutics Announces Positive Clinical Results from Two Studies of Its Intraprostatic Drug Elution Platform for Benign Prostatic Hyperplasia (BPH) at AUA 2026
SAN JOSE, May 14, 2026 /PRNewswire/ -- Resurge Therapeutics, a clinical-stage urology company, today announced positive clinical results from two...
Read moreDetails